Kevin D. Bunker, Chief Operating Officer at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 16,986 shares at $64.73 ($1.1M) on 2021-10-01, disclosed to the SEC on 2021-10-04.
Open-market sale of $1.1M ZNTL by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 350 | $0 | 0.0% |
| 2 | $64.73 | 1,416 | $92K | 8.3% |
| 3 | $64.73 | 1,416 | $92K | 8.3% |
| 4 | $65.80 | 3,121 | $205K | 18.7% |
| 5 | $65.80 | 3,121 | $205K | 18.7% |
| 6 | $66.89 | 3,679 |
| $246K |
| 22.4% |
| 7 | $66.89 | 3,679 | $246K | 22.4% |
| 8 | $67.44 | 204 | $14K | 1.3% |
| Total | $64.76 avg | 16,986 | $1.1M | 100% |
| Filing → |
| ZNTL | SELL | 2023-02-14 | $285K | — | Filing → |
| ZNTL | SELL | 2022-08-12 | $150K | — | Filing → |
| ZNTL | SELL | 2022-07-20 | $150K | — | Filing → |